Previous close | 67.00 |
Open | 67.10 |
Bid | 66.50 x 0 |
Ask | 66.90 x 0 |
Day's range | 64.40 - 67.10 |
52-week range | 49.05 - 99.10 |
Volume | |
Avg. volume | 23,103 |
Market cap | 1.675B |
Beta (5Y monthly) | 1.28 |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.03 |
Earnings date | 05 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 11 Mar 2021 |
1y target est | N/A |
With reference to company announcement 2/2023, stating the Danish Business Authority’s final decision on NNIT’s accounting treatment of an earn out payment related to the acquisition of Excellis Health Solutions, NNIT hereby publishes supplemental/corrective information to the annual report for 2021, including comparative numbers for 2020. The technical changes to historical accounting policies have no impact on total cash flow or the planned divestment of NNIT’s Infrastructure Operations Busine
NNIT A/S (“NNIT”) hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Danske Bank A/S regarding its indirect holdings of voting rights in NNIT A/S. Danske Bank A/S has reported that Danske Bank A/S indirectly holds an aggregate of 11,932,160 voting rights, corresponding to 4.77% of the total voting rights in NNIT A/S. The announcement is in accordance with section 30 of the Danish Capital Markets Act. Contact for further informationCarsten R
The Danish Business Authority has conducted a compliance review of NNIT A/S’ annual reports as stated in company announcement 12/2022. Following dialogue with NNIT, the Danish Business Authority has made a final decision affirming that the earn out payment related to the acquisition of Excellis Health Solutions should not be included in capitalized acquisition costs and goodwill, but instead expensed as remuneration as the earn out is in part subject to the selling shareholders’ continued employ